Research graph
References from Type II RAF Inhibitor Tovorafenib in Recurrent/Refractory Melanoma or Other Solid Tumors With BRAF Fusions or CRAF/RAF1 Fusions or Amplification: Phase II FIRELIGHT-1 Substudy. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1101/cshperspect.a011254
10.1101/cshperspect.a011254 · External reference
10.3390/cancers11101618
10.3390/cancers11101618 · External reference
10.1002/cncr.28864
10.1002/cncr.28864 · External reference
10.1038/s41392-023-01705-z
10.1038/s41392-023-01705-z · External reference
10.1158/2159-8290.cd-18-1321
10.1158/2159-8290.cd-18-1321 · External reference
10.1158/1078-0432.ccr-23-3981
10.1158/1078-0432.ccr-23-3981 · External reference
10.1002/onco.13519
10.1002/onco.13519 · External reference
10.1002/ijc.29825
10.1002/ijc.29825 · External reference
10.1093/nar/gkac888
10.1093/nar/gkac888 · External reference
10.1186/s12943-023-01903-x
10.1186/s12943-023-01903-x · External reference
10.1038/s41379-020-0510-7
10.1038/s41379-020-0510-7 · External reference
10.1172/jci147849
10.1172/jci147849 · External reference
A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas
2017 · External reference
10.1016/j.jbc.2023.104634
10.1016/j.jbc.2023.104634 · External reference
10.1038/s41591-023-02668-y
10.1038/s41591-023-02668-y · External reference
10.1158/1078-0432.ccr-24-3439
10.1158/1078-0432.ccr-24-3439 · External reference
Unresolved reference
External reference
10.1007/s00280-023-04544-5
10.1007/s00280-023-04544-5 · External reference
Activity of type II RAF inhibitor tovorafenib in a pediatric patient with a recurrent spindle cell sarcoma harboring a novel SNX8-BRAF gene fusion
External reference
Unresolved reference
External reference
10.1016/j.annonc.2024.11.006
10.1016/j.annonc.2024.11.006 · External reference
10.1016/j.critrevonc.2024.104276
10.1016/j.critrevonc.2024.104276 · External reference
10.1016/j.ejca.2008.10.026
10.1016/j.ejca.2008.10.026 · External reference
10.1200/jco.2017.72.7511
10.1200/jco.2017.72.7511 · External reference
10.1093/neuonc/noae274
10.1093/neuonc/noae274 · External reference
10.1093/annonc/mdx310
10.1093/annonc/mdx310 · External reference
10.1016/j.ctrv.2024.102721
10.1016/j.ctrv.2024.102721 · External reference
Unresolved reference
External reference
10.1200/edbk_404770
10.1200/edbk_404770 · External reference
10.1038/s41573-025-01147-y
10.1038/s41573-025-01147-y · External reference
10.1016/j.pathol.2021.11.008
10.1016/j.pathol.2021.11.008 · External reference
10.3389/fmolb.2020.00122
10.3389/fmolb.2020.00122 · External reference
10.1158/2159-8290.cd-20-0522
10.1158/2159-8290.cd-20-0522 · External reference
10.1093/oncolo/oyaf093
10.1093/oncolo/oyaf093 · External reference
10.1016/j.jmoldx.2019.03.008
10.1016/j.jmoldx.2019.03.008 · External reference
